Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
2
×
san diego blog main
san diego top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akcea therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
anylam pharmaceuticals
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech
biotech ipos
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cardiomyopathy
cell therapy
cidara therapeutics
cigna
What
drug
patients
sets
2
×
advantages
ago
akcea
alnylam
amyloidosis
approved
attr
available
bar
battle
bio
brings
debilitating
disease
expect
fda
gamble
genetic
market
medco’s
medicines
mover
new
oks
payers
pfizer
physicians
plan
pricing
rare
roundup
transthyretin
type
ubiome
undone
vertex’s
year
Language
unset
Current search:
sets
×
pfizer
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
